Antitrust Antitrust

Comment: Evolving US merger enforcement landscape suggests caution for dealmakers in 2022

The change in the US administration in 2021, which brought more aggressive enforcement and an effort to undertake significant merger reforms, suggests that companies should be more careful about regulatory risks in 2022.

The healthcare and technology industries are likely to continue to draw the attention of enforcers, who are also likely

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

LEARN MORE LEARN MORE

Latest News